Country: Իսրայել
language: եբրայերեն
source: Ministry of Health
FACTOR VIII (HUMAN)
MEDICI MEDICAL LTD, ISRAEL
B02BD02
אבקה להכנת תמיסה לזריקה
FACTOR VIII (HUMAN) 500 IU
תוך-ורידי
מרשם נדרש
INSTITUTO GRIFOLS S.A.,SPAIN,BARCELONA
COAGULATION FACTOR VIII
COAGULATION FACTOR VIII
Is indicated for the prevention and control of bleeding in patients with moderate or severe factor VIII deficiency due to classical hemophilia A . Fanhdi is not effective in controlling the bleeding of patients with Von Willebrond's disease.
2020-12-31